ACADIAN ASSET MANAGEMENT LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 224 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2023$88
-78.8%
1,940
-81.4%
0.00%
-100.0%
Q1 2023$416
+82.5%
10,403
+109.5%
0.00%
+100.0%
Q4 2022$228
-99.3%
4,966
+544.9%
0.00%
Q3 2022$31,000
-22.5%
770
+81.6%
0.00%
Q2 2021$40,000
-20.0%
424
+16.5%
0.00%
Q4 2020$50,0003640.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2022
NameSharesValueWeighting ↓
First Light Asset Management, LLC 437,512$31,772,0002.80%
RTW INVESTMENTS, LP 1,373,284$99,728,0002.06%
Rock Springs Capital Management LP 1,028,109$74,661,0001.88%
Privium Fund Management B.V. 112,727$8,186,0001.81%
Avidity Partners Management LP 869,000$63,107,0001.31%
SUVRETTA CAPITAL MANAGEMENT, LLC 525,100$38,133,0001.16%
Boxer Capital, LLC 200,000$14,524,0000.75%
SECTOR GAMMA AS 46,221$3,357,0000.73%
FEDERATED HERMES, INC. 3,987,728$289,589,0000.65%
EMERALD ADVISERS, LLC 223,952$16,263,0000.62%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders